Multidrug resistance in breast cancer--is the jury in yet?
作者信息
Kaye S B
出版信息
J Natl Cancer Inst. 1997 Jul 2;89(13):902-3. doi: 10.1093/jnci/89.13.902.
PMID:9214663
Abstract
摘要
相似文献
1
Multidrug resistance in breast cancer--is the jury in yet?乳腺癌中的多药耐药性——定论已出了吗？
J Natl Cancer Inst. 1997 Jul 2;89(13):902-3. doi: 10.1093/jnci/89.13.902.
2
Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.乳腺癌中的多药耐药性：MDR1/gp170表达及其可能的功能意义的荟萃分析。
J Natl Cancer Inst. 1997 Jul 2;89(13):917-31. doi: 10.1093/jnci/89.13.917.
3
Transcriptional regulation of multidrug resistance gene expression.多药耐药基因表达的转录调控
Cancer Treat Res. 1994;73:57-68. doi: 10.1007/978-1-4615-2632-2_4.
4
Multidrug resistance--a multiplex phenomenon.多重耐药性——一种复杂的现象。
Nat Med. 1997 Apr;3(4):378-80. doi: 10.1038/nm0497-378.
5
Transcriptional regulation of multidrug resistance in breast cancer.乳腺癌多药耐药的转录调控
Breast Cancer Res Treat. 1994;31(2-3):263-71. doi: 10.1007/BF00666159.
6
Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.长期血清饥饿条件下生长的肺癌和乳腺癌细胞的化疗耐药性
J Cell Physiol. 2017 Aug;232(8):2033-2043. doi: 10.1002/jcp.25514. Epub 2017 Feb 28.
7
Role of gene amplification in drug resistance.基因扩增在耐药性中的作用。
Cancer Treat Res. 1994;73:167-200. doi: 10.1007/978-1-4615-2632-2_9.
8
BRCA2-deficient sarcomatoid mammary tumors exhibit multidrug resistance.BRCA2 缺陷型肉瘤样乳腺癌表现出多药耐药性。
Cancer Res. 2015 Feb 15;75(4):732-41. doi: 10.1158/0008-5472.CAN-14-0839. Epub 2014 Dec 15.
9
Unanswered questions about multidrug resistance.关于多药耐药性的未解决问题。
Cytotechnology. 1996;19(3):177-9. doi: 10.1007/BF00744209.
引用本文的文献
1
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.右维拉帕米与表柔比星治疗转移性乳腺癌无效患者的II期试验
Br J Cancer. 1998 Apr;77(7):1155-63. doi: 10.1038/bjc.1998.192.
Zotero 插件